L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine

Begum AKUZUM; Sinae KIM; Tam-Thanh NGUYEN; Jeawoo HONG; Siyoung LEE; Eunhye KIM; Joohee KIM; Yeook CHOI; Hyunjhung JHUN; Youngmin LEE; Hyunwoo KIM; Dong-Hyun SOHN; Soohyun KIM.
Immune Network ; : e19-2018.
Artículo en Inglés | WPRIM | ID: wpr-715079

Documentos relacionados

  1. New developments in rare vulvar and vaginal cancers.
  2. ESTRO/ESGO/SIOPe Guidelines for the management of patients with vaginal cancer.
  3. Comprehensive evaluation of vaginal intraepithelial neoplasia development after hysterectomy: insights into diagnosis and treatment strategies.
  4. Mullerian Polyp of the Vagina: Report of Three Cases of a Previously Undescribed Lesion With Discussion of the Differential Diagnosis.
  5. Dose-response relationship between volume base dose and tumor local control in definitive radiotherapy for vaginal cancer.
  6. High mitotic index has no prognostic significance in mixed tumor of the vagina.
  7. A custom-made brachytherapy applicator for recurrent endometrial and vaginal cancer: A dental technique for prosthesis fabrication.
  8. [Analysis of the factors associated with the long-term curative effect and prognosis of primary vaginal carcinoma].
  9. Is it possible to block cancer? The example of #VaginalCancer on Instagram.
  10. Definitive Radiotherapy in Invasive Vaginal Carcinoma: A Systematic Review.